Privia Health Group, Inc. $PRVA is BlackBarn Capital Partners LP's 6th Largest Position

Key Points

• BlackBarn Capital Partners LP increased its stake in Privia Health Group, Inc. by 13.1% during the first quarter, owning 750,000 shares and ranking it as their 6th largest holding.
• Institutional ownership is significant, with approximately 94.48% of Privia Health Group’s stock held by hedge funds and other institutional investors.
• Equity analysts have mixed ratings on Privia Health, with the consensus rating being a "Moderate Buy" and an average target price of $28.00.

BlackBarn Capital Partners LP increased its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 13.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 750,000 shares of the company's stock after acquiring an additional 86,603 shares during the period. Privia Health Group comprises 1.1% of BlackBarn Capital Partners LP's investment portfolio, making the stock its 6th biggest position. BlackBarn Capital Partners LP owned approximately 0.62% of Privia Health Group worth $16,838,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. US Bancorp DE lifted its stake in Privia Health Group by 2.4% during the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock worth $415,000 after acquiring an additional 429 shares in the last quarter. Park Avenue Securities LLC lifted its stake in Privia Health Group by 3.6% during the 1st quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock worth $342,000 after acquiring an additional 532 shares in the last quarter. CWM LLC lifted its stake in Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after acquiring an additional 604 shares in the last quarter. Financial Management Professionals Inc. lifted its stake in Privia Health Group by 28.7% during the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock worth $76,000 after acquiring an additional 754 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after acquiring an additional 1,521 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Stock Down 0.1%

NASDAQ:PRVA traded down $0.02 during mid-day trading on Thursday, reaching $21.74. 167,599 shares of the stock were exchanged, compared to its average volume of 833,812. The company has a 50 day simple moving average of $20.89 and a 200-day simple moving average of $22.68. The stock has a market capitalization of $2.67 billion, a P/E ratio of 197.61, a P/E/G ratio of 3.10 and a beta of 0.80. Privia Health Group, Inc. has a 1 year low of $16.47 and a 1 year high of $26.09.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The company had revenue of $521.15 million for the quarter, compared to analyst estimates of $466.97 million. During the same period in the previous year, the business posted $0.19 earnings per share. The firm's revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. As a group, research analysts predict that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on PRVA shares. Evercore ISI cut their price target on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. Piper Sandler cut their price target on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a report on Monday, August 11th. Barclays upped their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 27th. Zacks Research upgraded Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th. Finally, JPMorgan Chase & Co. upped their price target on Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a report on Wednesday, May 28th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Privia Health Group presently has an average rating of "Moderate Buy" and a consensus target price of $28.00.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.